These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. Costa P; Rusconi S; Mavilio D; Fogli M; Murdaca G; Pende D; Mingari MC; Galli M; Moretta L; De Maria A AIDS; 2001 May; 15(8):965-74. PubMed ID: 11399978 [TBL] [Abstract][Full Text] [Related]
3. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56. Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303 [TBL] [Abstract][Full Text] [Related]
4. Expression of p58.2 or CD94/NKG2A inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA Class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2A-expressing transfectant. Lin Chua H; Brahmi Z Cell Immunol; 2002 Sep; 219(1):57-70. PubMed ID: 12473268 [TBL] [Abstract][Full Text] [Related]
5. Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients. Ahmad R; Sindhu ST; Tran P; Toma E; Morisset R; Menezes J; Ahmad A J Med Virol; 2001 Nov; 65(3):431-40. PubMed ID: 11596074 [TBL] [Abstract][Full Text] [Related]
6. Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis. Dulphy N; Rabian C; Douay C; Flinois O; Laoussadi S; Kuipers J; Tamouza R; Charron D; Toubert A Int Immunol; 2002 May; 14(5):471-9. PubMed ID: 11978777 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma. Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295 [TBL] [Abstract][Full Text] [Related]
8. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304 [TBL] [Abstract][Full Text] [Related]
9. Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Norris S; Doherty DG; Curry M; McEntee G; Traynor O; Hegarty JE; O'Farrelly C Cancer Immunol Immunother; 2003 Jan; 52(1):53-8. PubMed ID: 12536240 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of KIR/NKAT2 and CD94 molecules on decidual and peripheral blood CD56bright and CD56dim natural killer cell subsets. Eidukaite A; Siaurys A; Tamosiunas V Fertil Steril; 2004 Mar; 81 Suppl 1():863-8. PubMed ID: 15019821 [TBL] [Abstract][Full Text] [Related]
11. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas. Kamarashev J; Burg G; Mingari MC; Kempf W; Hofbauer G; Dummer R Am J Pathol; 2001 May; 158(5):1593-8. PubMed ID: 11337356 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals. André P; Brunet C; Guia S; Gallais H; Sampol J; Vivier E; Dignat-George F Eur J Immunol; 1999 Apr; 29(4):1076-85. PubMed ID: 10229073 [TBL] [Abstract][Full Text] [Related]
14. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021 [TBL] [Abstract][Full Text] [Related]
15. Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype. Dukers DF; Vermeer MH; Jaspars LH; Sander CA; Flaig MJ; Vos W; Willemze R; Meijer CJ J Clin Pathol; 2001 Mar; 54(3):224-8. PubMed ID: 11253136 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts. Zeddou M; Rahmouni S; Vandamme A; Jacobs N; Frippiat F; Leonard P; Schaaf-Lafontaine N; Vaira D; Boniver J; Moutschen M Retrovirology; 2007 Oct; 4():72. PubMed ID: 17927817 [TBL] [Abstract][Full Text] [Related]
17. HLA-class I-specific inhibitory receptors in HIV-1 infection. De Maria A; Moretta L Hum Immunol; 2000 Jan; 61(1):74-81. PubMed ID: 10658980 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487 [TBL] [Abstract][Full Text] [Related]
19. Multiple HLA-class I-specific inhibitory NK receptor expression and IL-4/IL-5 production by CD8+ T-cell clones in HIV-1 infection. De Maria A; Mavilio D; Costa P; Dignetti P; Fogli M; Mingari MC Immunol Lett; 2000 Jun; 72(3):179-82. PubMed ID: 10880839 [TBL] [Abstract][Full Text] [Related]
20. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]